GA
RDY icon

Geneva Advisors’s Dr. Reddy's Laboratories RDY Stock Holding History

Geneva Advisors’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-27,805
Closed -$355K – 688
2015
Q3 		$355K Sell
27,805
-11,015
-28% -$137K 0.01% 449
2015
Q2 		$430K Sell
38,820
-12,305
-24% -$136K 0.01% 450
2015
Q1 		$584K Buy
+51,125
New +$542K 0.01% 386

Other funds holding RDY

Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VAM
Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return
BG
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Geneva Advisors's RDY Position: Q4 2015 in Review

Geneva Advisors sold out of Dr. Reddy's Laboratories (RDY) in Q4 2015, closing a stake of 27,805 shares — an estimated $355K sold.

Geneva Advisors first reported a position in RDY in Q1 2015 and held it in 3 quarters. The position peaked at $584K in Q1 2015. 174 funds tracked by Wall St. Rank hold RDY as of Q4 2015.

  • Geneva Advisors reported no remaining Dr. Reddy's Laboratories position as of Q4 2015 after selling out during the quarter.
  • Geneva Advisors sold 27,805 Dr. Reddy's Laboratories shares in Q4 2015, an estimated $355K.
  • Geneva Advisors first reported a position in Dr. Reddy's Laboratories in Q1 2015 and held it in 3 quarters.
  • Geneva Advisors's Dr. Reddy's Laboratories position peaked at $584K in Q1 2015.
  • 174 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2015.

Based on Geneva Advisors's 13F filing for Q4 2015, filed 4 Feb 2016.